Should a QP audit CROs and Investigators?
Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
Register now for ECA's GMP Newsletter
As third set in row of Q&A documents, the European QP Association has published a Q&A document on IMP-related questions.
The new set of questions (on the European QP Association website) is dealing with topics like:
- Completeness of the IMPD
- Reanalysis of IMPs
- Audits
- Contracts
Related GMP News
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials
03.04.2025EMA Concept Paper on Model Informed Drug Development
20.03.2025End of the Transition Period for Clinical Trials
11.02.2025Final ICH E6(R3) Guideline on GCP released
11.02.2025FDA issues Draft Guidance on Handling Protocol Deviations in Clinical Trials